Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
glucosamine + chondroitin + hyaluronic acid
- Development stage
- Unknown
- Lead developer
- Pharmex Group
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Oral
01
Overview
Giamaks Complex is a combination chondroprotective product developed by Pharmex Group in collaboration with Omnifarm. It is formulated with three primary active ingredients: glucosamine hydrochloride, chondroitin sulfate, and sodium hyaluronate. The product is designed to slow the degeneration of cartilage and bone tissue in patients suffering from degenerative-dystrophic diseases of the musculoskeletal system, such as osteoarthritis and osteochondrosis. Glucosamine and chondroitin serve as essential substrates for the biosynthesis of the cartilage matrix and help inhibit catabolic enzymes that degrade joint tissues. Sodium hyaluronate acts to restore the viscoelastic properties of the synovial fluid, thereby improving joint lubrication and shock absorption. In Ukraine, where it was developed, Giamaks Complex is marketed as a dietary supplement intended for therapeutic support of joint health.
- Brand names
- Giamaks ComplexГіамакс Комплекс
- Other names
- Giamaks Complex®
02
Targets
CD44 (CD44 antigen)TLR4 (Toll-like receptor 4)
Beyond the preview
Go deeper on glucosamine + chondroitin + hyaluronic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on glucosamine + chondroitin + hyaluronic acid.